BDXB

Q: What is the price of Becton Dickinson (BDXB) today?

The current price of Becton Dickinson (BDXB) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Becton Dickinson (BDXB) pay dividends?

Becton Dickinson (BDXB) did not pay dividends over the past year.

Becton Dickinson and Company

Price

$ -

return (12m)

0.00%

p/e

8.75

p/bv

0.54

DIVIDEND YIELD

0.00%

BDXB price

BDXB

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment BDXB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BDXB

review the fundamentals of Becton Dickinson shares

P/E

8.75

Sector: -2.14 Industry: -1.71

P/S (PSR)

0.73

Sector: 1.94 Industry: 0.71

P/BV

0.54

Sector: 2.13 Industry: 1.90

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

2.89%

Sector: -25.39% Industry: -14.37%

ROE

6.12%

Sector: -29.75% Industry: -28.71%

ROIC

Sector: -418.64% Industry: -113.23%

NET MARGIN

8.36%

Sector: -27.73% Industry: -15.57%

GROSS MARGIN

45.25%

Sector: 44.91% Industry: 30.81%

OPERATING MARGIN

30.85%

Sector: -22.84% Industry: -7.79%

EV/EBITDA

2.37

Sector: -0.35 Industry: 0.83

EV/EBIT

3.87

Sector: -1.68 Industry: 2.65

PRICE-TO-ASSETS

0.25

Sector: 1.14 Industry: 0.84

BVPS

89.93

Sector: 3.83 Industry: 5.19

EPS

5.50

Sector: -0.89 Industry: -0.57

EQUITY-TO-ASSETS RATIO

0.47

Sector: 0.44 Industry: 0.27

LIABILITIES / ASSETS

0.53

Sector: 0.46 Industry: 0.48

CAGR REVENUE 5 YEARS

-1.15%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-1.26%

Sector: - Industry: -

FAIR VALUE OF Becton Dickinson ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside/Downside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals BDXB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	41.59	35.99	86.53%	0.65%	$ 858.38 B	31.66%
ISRG	56.96	9.07	15.92%	0.00%	$ 162.68 B	28.38%
TMO	27.82	3.48	12.52%	0.35%	$ 186.54 B	15.05%
SNY	12.68	1.38	10.86%	4.67%	$ 115.62 B	18.68%
NVS	21.29	6.40	30.04%	4.48%	$ 297.73 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.58	2.30	9.38%	2.41%	$ 113.37 B	13.00%
GSK	15.39	5.50	35.71%	3.00%	$ 117.42 B	17.48%
CVS	56.86	1.33	2.35%	3.36%	$ 100.53 B	0.44%
BSX	31.39	0.00	0.00%	0.00%	$ 90.98 B	14.44%
TMDX	19.73	7.94	40.22%	0.00%	$ 3.75 B	31.43%
HCA	17.15	-41.99	-244.82%	0.58%	$ 116.34 B	8.97%
IDXX	44.22	29.19	65.99%	0.00%	$ 46.85 B	24.62%
RMD	22.49	5.29	23.51%	1.02%	$ 33.42 B	27.53%
DHR	38.03	2.62	6.88%	0.66%	$ 137.43 B	14.71%
INMD	9.25	1.27	13.73%	0.00%	$ 868.14 M	25.32%
PHG	25.94	2.09	8.06%	3.13%	$ 26.91 B	5.07%
FMS	11.96	0.81	6.75%	3.34%	$ 13.50 B	5.02%
SYK	40.02	5.79	14.48%	1.00%	$ 129.89 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

BDXB Historical Dividends

current DY: 0.00%

5-year average DY: 2.44%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/15/2023	03/01/2023	0,75000000
Dividends	11/15/2022	12/01/2022	0,75000000
Dividends	08/15/2022	09/01/2022	0,75000000
Dividends	05/15/2022	06/01/2022	0,75000000
Dividends	02/15/2022	03/01/2022	0,75000000
Dividends	11/15/2021	12/01/2021	0,75000000
Dividends	08/15/2021	09/01/2021	0,75000000
Dividends	05/15/2021	06/01/2021	0,75000000
Dividends	02/15/2021	03/01/2021	0,75000000
Dividends	11/15/2020	12/01/2020	0,75000000
Dividends	08/15/2020	09/01/2020	0,79170000

ABOUT Becton Dickinson

Becton Dickinson and Company

Average Investor10 user rating

4.0 (10 people)

United States

120 years

Founded: 1906

1963

Time since IPO - 63 years

72.000

Employees

Becton Dickinson and Company (United States) is listed on the NYSE and has a market capitalization of $13.76 Billions, with shareholders equity totaling $25.69 Billions.

The company employs approximately 72.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Becton Dickinson and Company reported $18.81 Billions in revenue, generating net income of $1.57 Billion.

Key financial metrics include a P/E ratio of 8.75, a price-to-book (P/B) ratio of 0.54, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BDXB.

Market cap

$ 13.76 Billions

Net worth

$ 25.69 Billions

$ 25,689,000,000.00

Assets

$ 54.39 Billions

$ 54,394,000,000.00

Total Shares Outstanding

285.65 Millions

285,645,000

Average Daily Trading Volume

$ 227.80 Thousand

$ 227,802.00

Sector

Health

Industry

Medical Supplies and Equipment

BDXB

BDXB revenue and profits

Financial Results BDXB

DRAG THE FRAME TO SEE MORE DATA

BDXB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.63 17,93% (12M)

P/E

56.86

3.36%

ROE

2.35%

P/BV

1.33

CI - Cigna

$ 272.65 --15,28% (12M)

P/E

10.78

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 37.26 --40,17% (12M)

P/E

-2.75

0.00%

ROE

-33.28%

P/BV

0.91

HUM - Humana

$ 196.30 --30,24% (12M)

P/E

19.94

1.79%

ROE

6.70%

P/BV

1.34

HCA - HCA Healthcare

$ 498.78 49,66% (12M)

P/E

17.15

0.58%

ROE

-244.82%

P/BV

-41.99

LLY - Eli Lilly

$ 923.03 26,51% (12M)

P/E

41.59

0.65%

ROE

86.53%

P/BV

35.99

NVS - Novartis

$ 153.41 47,40% (12M)

P/E

21.29

4.48%

ROE

30.04%

P/BV

6.40